Growth Metrics

INVO Fertility (IVF) Net Cash Flow Growth (1y) (2012 - 2025)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -53.07%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 17.60%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -562.50%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -283.58%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -564.44%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 76.43%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -31.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -394.13%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 57.36%
10 INVO Fertility 5.12 Mn 4.76 Mn 629,345.00 60.36%

Historic Data

Download Data 🔒
DateValue
Sep 30, 2025 60.36%
Jun 30, 2025 -160.17%
Mar 31, 2025 -59.20%
Dec 31, 2024 132.78%
Sep 30, 2024 -151.70%
Jun 30, 2024 123.32%
Mar 31, 2024 -88.43%
Dec 31, 2023 -320.90%
Sep 30, 2023 156.25%
Jun 30, 2023 -10.55%
Mar 31, 2023 213.72%
Dec 31, 2022 -120.12%
Sep 30, 2022 13.13%
Jun 30, 2022 -5.48%
Mar 31, 2022 -10.18%
Dec 31, 2021 -89.43%
Sep 30, 2021 -224.00%
Jun 30, 2021 -254.27%
Mar 31, 2021 -88.45%
Dec 31, 2020 1,291.74%
Sep 30, 2020 8.85%
Jun 30, 2020 392.66%
Mar 31, 2020 -131.23%
Dec 31, 2019 -129.68%
Sep 30, 2019 -279.30%
Jun 30, 2019 -157.57%
Mar 31, 2019 29,393.35%
Dec 31, 2018 -3,435.04%
Sep 30, 2018 -1,102.79%
Jun 30, 2018 3,274.42%
Mar 31, 2018 108.56%
Dec 31, 2017 91.06%
Sep 30, 2017 130.13%
Jun 30, 2017 78.36%
Mar 31, 2017 -64.18%
Dec 31, 2016 -128.14%
Sep 30, 2016 -263.19%
Jun 30, 2016 -280.80%
Mar 31, 2016 -1,274.97%
Dec 31, 2015 2,955.72%
Sep 30, 2015 1,580.42%
Jun 30, 2015 3,902.32%
Mar 31, 2015 154.27%
Dec 31, 2014 17.35%
Sep 30, 2014 -145.16%
Jun 30, 2014 -13.22%
Mar 31, 2014 -65.53%
Dec 31, 2013 151.36%
Sep 30, 2013 238.66%
Jun 30, 2013 -94.81%
Mar 31, 2013 -1,444.42%
Dec 31, 2012 -1,015.73%
Sep 30, 2012 49.50%